Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment
Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R (2018)
Publication Type: Journal article
Publication year: 2018
Journal
Book Volume: 194
Pages Range: 797-805
Journal Issue: 9
DOI: 10.1007/s00066-018-1329-8
Abstract
Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.
Authors with CRIS profile
Involved external institutions
Universitätsklinikum Heidelberg
Germany (DE)
Vivantes - Netzwerk für Gesundheit GmbH
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Paracelsus Medizinische Privatuniversität
Austria (AT)
St. Claraspital AG
Switzerland (CH)
Universität Witten/Herdecke
Germany (DE)
Marienhospital Stuttgart
Germany (DE)
St. Vincentius-Kliniken / ViDia Kliniken
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Universitätsklinikum Mannheim
Germany (DE)
Universitätsklinikum Düsseldorf
Germany (DE)
Germany (DE)
Vivantes - Netzwerk für Gesundheit GmbH
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Paracelsus Medizinische Privatuniversität
Austria (AT)
St. Claraspital AG
Switzerland (CH)
Universität Witten/Herdecke
Germany (DE)
Marienhospital Stuttgart
Germany (DE)
St. Vincentius-Kliniken / ViDia Kliniken
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Universitätsklinikum Mannheim
Germany (DE)
Universitätsklinikum Düsseldorf
Germany (DE)
How to cite
APA:
Krug, D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2018). Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment. Strahlentherapie und Onkologie, 194(9), 797-805. https://doi.org/10.1007/s00066-018-1329-8
MLA:
Krug, David, et al. "Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment." Strahlentherapie und Onkologie 194.9 (2018): 797-805.
BibTeX: Download